# US 2025/0152961 A1 · Photobiomodulation systems utilizing monitoring or electrical stimulation and methods of making and using

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0152961 A1
- Document ID: US20250152961A1
- Status: Published application
- Kind: A1
- Application number: 18/935,277
- Filed: 2024-11-01
- Published: 2025-05-15
- Earliest claimed: 2023-11-09
- Assignees: Boston Scientific Neuromodulation Corporation
- Applicants: Boston Scientific Neuromodulation Corporation
- Inventors: Michael A. Moffitt; Hari Hara Subramanian; Rafael Carbunaru
- Web page: https://patentgrep.com/patent/US20250152961A1

## CPC

- A61N 5/0601: {Apparatus for use inside the body}
- A61B 5/24: Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61N 1/05: for implantation or insertion into the body, e.g. heart electrode (A61N1/06 takes precedence)
- A61N 1/0534: {Electrodes for deep brain stimulation}
- A61N 1/36067: {Movement disorders, e.g. tremor or Parkinson disease (stimulating motor muscle A61N1/36003)}
- A61N 1/36139: {with automatic adjustment}
- A61N 5/0622: {Optical stimulation for exciting neural tissue}
- A61N 2005/0612: {using probes penetrating tissue; interstitial probes}
- A61N 2005/0626: {Monitoring, verifying, controlling systems and methods}
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

A method for photobiomodulation includes emitting light from a lead implanted in a patient using a light source according to a first delivery program to photobiomodulate the patient; monitoring at least one biomarker, an evoked signal, or a local field potential to monitor at least one effect of the photobiomodulation; determining, by a processor, whether the monitoring of the at least one biomarker meets a change condition; when the monitoring of the at least one biomarker meets a change condition, determining, by the processor, a change to the first delivery program to produce a second delivery program; and emitting light from the implanted lead according to the second delivery program. Other aspects include coordinated photobiomodulation and electrical stimulation.

## Claims

### Claim 1

A method for photobiomodulation, the method comprising:
emitting light from a lead implanted in a patient using a light source according to a first delivery program to photobiomodulate the patient;
monitoring at least one biomarker to monitor at least one effect of the photobiomodulation;
determining, by a processor, whether the monitoring of the at least one biomarker meets a change condition;
when the monitoring of the at least one biomarker meets a change condition, determining, by the processor, a change to the first delivery program to produce a second delivery program; and
emitting light from the implanted lead according to the second delivery program.

### Claim 2 (depends on 1)

The method of claim 1, wherein the change condition comprises a magnitude or a rate of the biomarker.

### Claim 3 (depends on 1)

The method of claim 1, wherein the change condition comprises a magnitude or rate of a change in a magnitude of the biomarker.

### Claim 4 (depends on 1)

The method of claim 1, wherein the monitoring comprises monitoring the at least one biomarker using at least one sensor.

### Claim 5 (depends on 4)

The method of claim 4, wherein at least one of the at least one sensor is an implanted sensor.

### Claim 6 (depends on 4)

The method of claim 4, wherein at least one of the at least one sensor is a worn or wearable sensor.

### Claim 7 (depends on 1)

The method of claim 1, wherein the monitoring or the determining is performed at a regular periodic interval.

### Claim 8 (depends on 1)

The method of claim 1, wherein the biomarker comprises dopamine or acetylcholine.

### Claim 9 (depends on 1)

The method of claim 1, wherein the emitting comprises emitting the light for neural protection, neural survival, or neural growth.

### Claim 10

A method for photobiomodulation of tissue of a brain of a patient, the method comprising:
emitting light at a first site in the brain from an implanted lead using a light source according to a first delivery program to photobiomodulate the tissue;
in response to the emitting, monitoring an evoked signal or local field potential at a second site in the brain that is spaced apart from the first site by at least 5 mm;
determining, by a processor, whether the monitoring of the evoked signal or local field potential meets a change condition;
when the monitoring of the evoked signal or local field potential meets a change condition, determining a change to the first delivery program to produce a second delivery program; and
emitting light from the implanted lead according to the second delivery program.

### Claim 11 (depends on 10)

The method of claim 10, wherein the change condition comprises a magnitude or change in a magnitude of the evoked signal.

### Claim 12 (depends on 10)

The method of claim 10, wherein the change condition comprises a magnitude or a change in magnitude of a local field potential.

### Claim 13 (depends on 10)

The method of claim 10, wherein the monitoring or the determining is performed at a regular periodic interval.

### Claim 14 (depends on 10)

The method of claim 10, wherein the determining comprises determining whether the monitoring of the evoked signal or local field potential meets the change condition accounting for an additional factor selected from a circadian rhythm or a current activity of the patient.

### Claim 15

A method for stimulation and photobiomodulation of tissue of a patient, the method comprising:
providing at least one lead implanted in the patient;
stimulating the tissue using at least one electrode disposed on the at least one lead; and
in conjunction with the stimulation, emitting light from the at least one lead using a light source to up-regulate or down-regulate at least one biomarker in the tissue.

### Claim 16 (depends on 15)

The method of claim 15, wherein the at least one lead comprises an optical/electrical lead comprising the at least one electrode and at least one light emitter.

### Claim 17 (depends on 15)

The method of claim 15, wherein the at least one lead comprises at least one electrical stimulation lead comprising the at least one electrode and at least one optical lead, different from the at least one electrical stimulation lead, comprising at least one light emitter.

### Claim 18 (depends on 15)

The method of claim 15, wherein the biomarker comprises dopamine or acetylcholine.

### Claim 19 (depends on 15)

The method of claim 15, monitoring the at least one biomarker and determining, by a processor, whether the monitoring of the at least one biomarker meets a change condition.

### Claim 20 (depends on 19)

The method of claim 19, further comprising, when the monitoring of the at least one biomarker meets a change condition, determining, by the processor, a change to either the stimulating of the tissue or the emitting of the light.
